First Trust Nyse Arca Biotechnology Index Fund ETF Forecast

Buy or Hold candidate since May 19, 2026 Gain 18.57%

The First Trust NYSE Arca Biotechnology ETF price fell by -3.03% on the last day (Friday, 31st Jul 2026) from $252.64 to $245.00. During the last trading day the ETF fluctuated 3.01% from a day low at $243.46 to a day high of $250.79. The price has fallen in 6 of the last 10 days and is down by -1.4% for this period. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -12 thousand shares and in total, 36 thousand shares were bought and sold for approximately $8.91 million.

Given the current short-term trend, the ETF is expected to rise 24.14% during the next 3 months and, with a 90% probability hold a price between $304.13 and $337.39 at the end of this 3-month period.

FBT Signals & Forecast

The First Trust NYSE Arca Biotechnology ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $248.92. On a fall, the ETF will find some support from the long-term average at approximately $244.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -4.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for First Trust NYSE Arca Biotechnology ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $214.10 and $211.77. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, First Trust NYSE Arca Biotechnology finds support just below today's level at $214.10. If this is broken, then the next support from accumulated volume will be at $211.77 and $209.54.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $7.33 between high and low, or 3.01%. For the last week the ETF has had daily average volatility of 1.82%.

Our recommended stop-loss: $234.62 (-4.23%) (This ETF has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (FBT) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect First Trust NYSE Arca Biotechnology Index Fund to open at $246.42, and during the day (based on 14 day Average True Range), to move between $242.69 and $247.30, which gives a possible trading interval of +/-$4.62 (+/-1.90%) up or down from last closing price. If First Trust NYSE Arca Biotechnology Index Fund takes out the full calculated possible swing range there will be an estimated 1.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $247.39 (0.98%) than the support at $214.10 (12.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is First Trust NYSE Arca Biotechnology Index Fund ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for First Trust NYSE Arca Biotechnology ETF to perform well in the short-term.

Current score: 2.872 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $246.42 ( 0.580%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk